Peptide Laws in Peru
PE · Americas · 23 peptides tracked
Are Peptides Legal in Peru?
Peru has low pharmaceutical enforcement through DIGEMID, and many pharmacies are quite accessible without strict prescription requirements. Wellness tourism is growing, and some clinics offer peptide-related treatments. Research peptides are not widely sold domestically but can be imported with little interference. Travelers should exercise caution with product quality, as the relaxed environment also means less quality assurance.
4
Legal11
Grey Area2
Prescription6
BannedCan You Buy Peptides in Peru?
4 peptide(s) are legal to buy in Peru, including GHK-Cu, NAD+, Glutathione, Vitamin B12. 2 peptide(s) require a valid prescription, including Tirzepatide, Semaglutide. 11 peptide(s) fall into a legal grey area: Selank, MOTS-c, AOD-9604, Semax, DSIP, and 6 more. These may be available for research purposes but their legality for personal use is ambiguous. 6 peptide(s) are banned: Retatrutide, TB-500, CJC-1295, Ipamorelin, BPC-157, and 1 more. Purchasing or possessing these is illegal.
Traveling to Peru with Peptides
When traveling to Peru with peptides, the legality depends on each peptide's classification. Do not bring banned substances (Retatrutide, TB-500, CJC-1295, Ipamorelin, BPC-157, and 1 more) — these could result in criminal penalties at customs. Prescription peptides (Tirzepatide, Semaglutide) typically require documentation such as a prescription or doctor's letter when crossing borders. Enforcement in Peru is rated as "Lenient." Always declare pharmaceutical products at customs and carry documentation of any prescriptions.
New to peptides? Start with the basics on peptide.camp →
Need to source peptides for Peru? Get verified wholesale quotes on peptide.broker →
Traveling to Peru with peptides? TSA tips, packing guides & the peptide travel case on peptide.travel →
Peptide Regulations in Peru
| Peptide | Status | Rx Required | Schedule | Detail | Source |
|---|---|---|---|---|---|
| Retatrutide | Banned | No | Sin Registro Sanitario | No registro sanitario from DIGEMID, which is an indispensable requirement for commercialisation. DIGEMID issued Alerta 094-2026 on 17 August 2026 over illegal web commercialisation of Retatrutide 10 mg and 50 mg vials, noting the seller also lacked authorisation to operate as a pharmaceutical establishment for import, storage or sale. Unregistered products may be imported only under the provisional authorisations in DS 016-2011-SA art. 20, of which the relevant limb is individual prevention and treatment, requiring medical justification from a prescribing health professional plus a report on the product characteristics. | Official |
| Selank | Grey Area | No | Unregistered | Russian nootropic. Not available through mainstream channels. | Secondary |
| Tirzepatide | Prescription | Yes | DIGEMID Registered | DIGEMID registered. Prescription required. | Secondary |
| MOTS-c | Grey Area | No | Unregistered | Not specifically regulated. Minimal availability. | Secondary |
| TB-500 | Banned | No | Sin Registro Sanitario | No registro sanitario from DIGEMID, which is an indispensable requirement for commercialisation. DIGEMID issued Alerta 094-2026 on 17 August 2026 over illegal web commercialisation of Retatrutide 10 mg and 50 mg vials, noting the seller also lacked authorisation to operate as a pharmaceutical establishment for import, storage or sale. Unregistered products may be imported only under the provisional authorisations in DS 016-2011-SA art. 20, of which the relevant limb is individual prevention and treatment, requiring medical justification from a prescribing health professional plus a report on the product characteristics. | Official |
| GHK-Cu | Legal | No | Cosmetic | Topical/cosmetic use unrestricted. | Secondary |
| AOD-9604 | Grey Area | No | Unregistered | Not specifically regulated. | Secondary |
| Semaglutide | Prescription | Yes | DIGEMID Registered | DIGEMID registered. Prescription required. | Secondary |
| CJC-1295 | Banned | No | Sin Registro Sanitario | No registro sanitario from DIGEMID, which is an indispensable requirement for commercialisation. DIGEMID issued Alerta 094-2026 on 17 August 2026 over illegal web commercialisation of Retatrutide 10 mg and 50 mg vials, noting the seller also lacked authorisation to operate as a pharmaceutical establishment for import, storage or sale. Unregistered products may be imported only under the provisional authorisations in DS 016-2011-SA art. 20, of which the relevant limb is individual prevention and treatment, requiring medical justification from a prescribing health professional plus a report on the product characteristics. | Official |
| Semax | Grey Area | No | Unregistered | Russian nootropic. Not available through mainstream channels. | Secondary |
| Ipamorelin | Banned | No | Sin Registro Sanitario | No registro sanitario from DIGEMID, which is an indispensable requirement for commercialisation. DIGEMID issued Alerta 094-2026 on 17 August 2026 over illegal web commercialisation of Retatrutide 10 mg and 50 mg vials, noting the seller also lacked authorisation to operate as a pharmaceutical establishment for import, storage or sale. Unregistered products may be imported only under the provisional authorisations in DS 016-2011-SA art. 20, of which the relevant limb is individual prevention and treatment, requiring medical justification from a prescribing health professional plus a report on the product characteristics. | Official |
| NAD+ | Legal | No | Supplement | Available as supplement. No specific restrictions. | Secondary |
| BPC-157 | Banned | No | Sin Registro Sanitario | No registro sanitario from DIGEMID, which is an indispensable requirement for commercialisation. DIGEMID issued Alerta 094-2026 on 17 August 2026 over illegal web commercialisation of Retatrutide 10 mg and 50 mg vials, noting the seller also lacked authorisation to operate as a pharmaceutical establishment for import, storage or sale. Unregistered products may be imported only under the provisional authorisations in DS 016-2011-SA art. 20, of which the relevant limb is individual prevention and treatment, requiring medical justification from a prescribing health professional plus a report on the product characteristics. | Official |
| DSIP | Grey Area | No | Unregistered | — | Unsourced |
| Epithalon | Grey Area | No | Unregistered | — | Unsourced |
| Glutathione | Legal | No | Supplement | — | Unsourced |
| HGH | Grey Area | No | Unregistered | — | Unsourced |
| KPV | Grey Area | No | Unregistered | — | Unsourced |
| Melanotan II | Grey Area | No | Unregistered | — | Unsourced |
| Liraglutide | Grey Area | No | Unregistered | — | Unsourced |
| MK-677 | Banned | No | Sin Registro Sanitario | No registro sanitario from DIGEMID, which is an indispensable requirement for commercialisation. DIGEMID issued Alerta 094-2026 on 17 August 2026 over illegal web commercialisation of Retatrutide 10 mg and 50 mg vials, noting the seller also lacked authorisation to operate as a pharmaceutical establishment for import, storage or sale. Unregistered products may be imported only under the provisional authorisations in DS 016-2011-SA art. 20, of which the relevant limb is individual prevention and treatment, requiring medical justification from a prescribing health professional plus a report on the product characteristics. | Official |
| Vitamin B12 | Legal | No | Supplement | — | Unsourced |
| PT-141 | Grey Area | No | Unregistered | — | Unsourced |
About the sources on this page
Entries marked Official cite a government regulator, legislation or an official gazette. Entries marked Secondary rest on consultancy, law firm, news or academic reporting rather than the regulator itself. Some entries currently carry no source at all.
We show these entries rather than hiding them, but they should not be relied on. Nothing on this site is legal advice. Verify against the national regulator before acting, and if you can point us at a better source please submit an update.
Data is researcher-verified but not legal advice. Always consult local regulations before purchasing, importing, or traveling with peptides. Last verified: 2026-02-28.